Epratuzumab

WikiDoc Resources for Epratuzumab
Articles
Most recent articles on Epratuzumab Most cited articles on Epratuzumab Review articles on Epratuzumab Articles on Epratuzumab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Epratuzumab Images of Epratuzumab Photos of Epratuzumab Podcasts & MP3s on Epratuzumab Videos on Epratuzumab
Evidence Based Medicine
Cochrane Collaboration on Epratuzumab Bandolier on Epratuzumab TRIP on Epratuzumab
Clinical Trials
Ongoing Trials on Epratuzumab at Clinical Trials.gov Trial results on Epratuzumab Clinical Trials on Epratuzumab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Epratuzumab NICE Guidance on Epratuzumab NHS PRODIGY Guidance FDA on Epratuzumab CDC on Epratuzumab
Books
Books on Epratuzumab
News
Epratuzumab in the news Be alerted to news on Epratuzumab News trends on Epratuzumab
Commentary
Blogs on Epratuzumab
Definitions
Definitions of Epratuzumab
Patient Resources / Community
Patient resources on Epratuzumab Discussion groups on Epratuzumab Patient Handouts on Epratuzumab Directions to Hospitals Treating Epratuzumab Risk calculators and risk factors for Epratuzumab
Healthcare Provider Resources
Symptoms of Epratuzumab Causes & Risk Factors for Epratuzumab Diagnostic studies for Epratuzumab Treatment of Epratuzumab
Continuing Medical Education (CME)
CME Programs on Epratuzumab
International
Epratuzumab en Espanol Epratuzumab en Francais
Business
Epratuzumab in the Marketplace Patents on Epratuzumab
Experimental / Informatics
List of terms related to Epratuzumab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Epratuzumab is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as lupus (SLE).

See also

• Biotechnology
• Immunology
• Oncology